HMC-1

mast cell line

Cell Type:
Granulocyte
Tissue Origin:
Species:
human
Research Area:
Immunotherapy / Hematology
Cell Characteristics:
Suspension

Transfection Information

Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol Kit Program Cells Efficiency Viable Cells Substrate Format Platform
L T-020 40-50% 80-90% µg 100 µl I/II/2b
V T-020 53% 76% Plasmid (general) 1 µg 100 µl I/II/2b
L T-020 61% 93% Plasmid (general) 1 µg 100 µl I/II/2b
V T-030 72% 100% Plasmid (general) 1 µg 100 µl I/II/2b
L T-030 60% 100% Plasmid (general) 1 µg 100 µl I/II/2b

Citations

Categories:
Transfection 
Authors:
Vong L, D'Acquisto F, Pederzoli-Ribeil M, Lavagno L, Flower RJ, Witko-Sarsat V, Perretti M 
In:
J Biol Chem (2007) 282(41): 29998-30004 
Categories:
Transfection 
Authors:
Belot MP, Abdennebi-Najar L, Gaudin F, Lieberherr M, Godot V, Taieb J, Emilie D, Machelon V 
In:
Am J Physiol Endocrinol Metab (2007) 292(5): E1410-7